Abstract
There are currently multiple international bodies suggesting legal and ethical frameworks for regulating international biobank research. One will for obvious reasons find inconsistencies in terminology and differences in procedures suggested for biobank research among all those guidelines, emanating from many different moral and legal traditions. A central question is whether this constitutes a threat to making progress in international biobank research, as some have argued. In this book, Chapter 1 suggests that there are sufficient and well-established instruments and ethical principles available to guide research in this area. Basically I argue that there is no need for a top-down superstructure of detailed rules and guidelines to be imposed on biobank researchers. With the existing ethical review boards (ERBs) playing a central role guided by well-established ethical guidelines (e.g., the Helsinki Declaration) and solutions to specific ethical problems suggested in the literature, self-regulation by researchers providing arguments for balancing of interests in association with different research initiatives and protocols will be sufficient. Traditional information and consent procedures suffice and data protection implies a sovereign right of the individual citizen to grant the use of biobank material and personal data that is needed for biobank research. Clearly, there may still be inconsistencies in terminology when researchers of different nationalities meet in common enterprises, but both they and the ERBs are well equipped to sort out what is actually meant and propose different instruments for, for example, coding following recently established nomenclatures. The existing ERBs should play the key role, guided by the sound argumentation of the researchers in their applications to the board.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Knoppers, B.M., Abdul-Rahman, M.H., Bédard, K. (2007) Genomic databases and international collaboration. Kings Law Journal. 18, 291–311.
Gibbons, S.M.C., Kaye, J. (2007) Governing genetic databases: collection, storage and use. Kings Law Journal. 18, 201–208.
Chadwick, R., Cutter, M. (2007) The impact of biobanks on ethical frameworks. In The ethics and governance of human genetic databases (Häyry, M., Chadwick, R., Árnason, V., Árnason, G., eds.), Cambridge University Press, New York, pp. 219–226.
Murray, T.H. (1997) Genetic exceptionalism and “Future Diaries”: is genetic information different from other medical information? In Genetic secrets: protecting privacy and confidentiality in the genetic era (Rothstein, M.A., ed.), Yale University Press, New Haven, pp. 60–73.
Wendler, D. (2006) One-time general consent for research on biological samples. BMJ. 332, 544–547.
Kettis-Lindblad, Å., Ring, L., Viberth, E., Hansson, M.G. (2007) Perceptions of potential donors in the Swedish public towards information and consent procedures in relation to use of human tissue samples in biobanks: population based study. Scandinavian Journal of Public Health. 35(2), 148–156.
Caulfield, T. (2007) Biobanks and blanket consent: the proper place of the public good and public perception rationales. Kings Law Journal. 18, 209–226.
Williams, C. (2005) Australian attitudes to DNA sample banks and genetic screening. Current Medical Research and Opinions. 21, 1773–1775.
Helgesson, G., Ludvigsson, J., Gustafsson Stolt, U. (2005) How to handle informed consent in longitudinal studies when participants have a limited understanding of the study. Journal of Medical Ethics. 31, 670–673.
Rose, H. (2003) An ethical dilemma. The rise and fall of human genomics – the model biotech company? Nature. 425, 123–124.
Hansson, M.G. (2005) Building on relationships of trust in biobank research. Journal of Medical Ethics. 31, 415–418.
Hansson, M.G. (2006) Combining efficiency and concerns about integrity when using human biobanks. Studies in History and Philosophy of the Biological and Biomedical Sciences. 37, 520–532.
Hoeyer, K., Olofsson, B-O., Mjörndal, T., Lynöe, N. (2004) Informed consent and biobanks: a population-based study of attitudes towards tissue donation for genetic research. Scandinavian Journal of Public Health. 32, 224–229.
McQuillan, G., Porter, K.S., Agelli, M., Kington, R. (2003) Consent for genetic research in a general population: the NHANES experience. Genetics in Medicine. 5, 35–42.
O’Neill, O. (2003) Some limits of informed consent. Journal of Medical Ethics. 29, 4–7.
Knoppers, B.M., Chadwick, R. (2005) Human genetic research: emerging trends in ethics. Nature Reviews Genetics. 6, 75–79.
Hansson, M.G. (2008) The private sphere. An emotional territory and its agent. In Philosophical Studies in Contemporary Culture, Monograph, Springer, p. 182.
Hansson, M.G. (1991) Human dignity and animal well-being. A Kantian contribution to biomedical ethics. Acta Universitatis Upsaliensis. Uppsala Studies in Social Ethics 12, Uppsala.
Hansson, M.G. (1998) Balancing the quality of consent. Journal of Medical Ethics. 24(3), 182–187.
Hansson, M.G. (2007) For the safety and benefit of current and future patients. Pathobiology. 74, 198–205.
Árnason, V. (2004) Coding and consent: moral challenges of the database project in Iceland. Bioethics. 18, 27–49.
Hansson, M.G., Dillner, J., Bartram, C.R., Carlsson, J., Helgesson, G. (2006) Should donors be allowed to give broad consent to future biobank research? The Lancet Oncology. 7, 266–269.
Hansson, M.G. (2009) Ethics and biobanks. British Journal of Cancer. 100, 8–12.
Campbell, A.V. (2007) The ethical challenges of genetic databases: safeguarding altruism and trust. Kings Law Journal. 18, 227–246.
Sigstad, E., Lie, A.K., Luostarinen, T., Dillner, J., Jellum, E., Lehtinen, M., Thoresen, S., Abeler, V. (2002) A prospective study of the relationship between prediagnostic human papillomavirus seropositivity and HPV DANN in subsequent cervical carcinomas. British Journal of Cancer. 87(2), 175–180.
Kaijser, M. (2003) Examples from Swedish biobank research. In: Biobanks as resources of health (Hansson, M.G., Levin, M., eds.), Uppsala University, Uppsala, pp. 33–50.
Lindberg, B.S. (2003) Clinical data – a necessary requirement for realizing the potential of biobanks. In: Biobanks as resources of health (Hansson, M.G., Levin, M., eds.), Uppsala University, Uppsala, pp. 21–32.
Sundstrom, P., Juto, P., Wadell, G., Hallmans, G., Svenningsson, A., Nystrom, L., Dillner, J., Forsgren, L. (2004) An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology. 62(12), 2277–2282.
Council of Europe (1997) Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: Convention on Human Rights and Biomedicine. Oviedo, ETS No. 164.
Helgesson, G., Dillner, J., Carlson, J., Bartram, C.R., Hansson, M.G. (2007) Ethical framework for previously collected biobank samples. Nature Biotechnology. 25, 973–976.
Lag om genetisk integritet m.m. (Act on Genetic Integrity), 2006, p. 351.
Eriksson, S., Helgesson, G. (2005) Potential harms, anonymization, and the right to withdraw consent to biobank research. European Journal of Human Genetics. 13, 1071–1076.
EMEA (2002) Position paper on terminology in pharmacogenetics. Committee for Proprietary Medicinal Products (CPMP), EMEA/CPMP/3070/01.
Wolf, S.M., Lawrenz, F.P., Nelson, C.A., Kahn, J.P., Cho, M.K., Clayton, E.W., Fletcher, J.G., Georgieff, M.K., Hammerschmidt, D., Hudson, K., Illes, J., Kapur, V., Keane, M.A., Koenig, B.A., Leroy, B.S., McFarland, E.G., Paradise, J., Parker, L.S., Terry, S.F., Van Ness, B., Wilfond, B.S. (2008) Managing incidental findings in human subjects research: analysis and recommendations. The Journal of Law Medicine & Ethics 36(2), 219–248.
Armitage, P. (1998) Attitudes in clinical trials. Statistics in Medicine. 17, 2675–2683.
Helgesson, G. (2005) Children, longitudinal studies, and informed consent. Medicine, Health Care and Philosophy. 8, 307–313.
Acknowledgement
I am grateful to Alastair Campbell, Don Chalmers, and Terry Kaan Sheung-Hung for valuable comments to an earlier version of this chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Hansson, M.G. (2011). The Need to Downregulate: A Minimal Ethical Framework for Biobank Research. In: Dillner, J. (eds) Methods in Biobanking. Methods in Molecular Biology, vol 675. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59745-423-0_2
Download citation
DOI: https://doi.org/10.1007/978-1-59745-423-0_2
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-58829-995-6
Online ISBN: 978-1-59745-423-0
eBook Packages: Springer Protocols